| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1991PNAS...88.4186B |
| P356 | DOI | 10.1073/PNAS.88.10.4186 |
| P932 | PMC publication ID | 51623 |
| P698 | PubMed publication ID | 2034663 |
| P5875 | ResearchGate publication ID | 21120674 |
| P50 | author | Maurizia R Brunetto | Q56940371 |
| F Oliveri | Q68247622 | ||
| P2093 | author name string | H Will | |
| M Baldi | |||
| A Serra | |||
| G Verme | |||
| E Chiaberge | |||
| A Alfarano | |||
| G Saracco | |||
| M M Giarin | |||
| P2860 | cites work | A signal peptide encoded within the precore region of hepatitis B virus directs the secretion of a heterogeneous population of e antigens in Xenopus oocytes | Q33669396 |
| Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? | Q33762446 | ||
| Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli | Q34051296 | ||
| Immunoelectron microscopic observation of intrahepatic HBeAg in patients with chronic hepatitis B. | Q34756315 | ||
| Hepatitis B virus gene function: the precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen | Q35594167 | ||
| Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen | Q36802480 | ||
| Chronic type B hepatitis and the "healthy" HBsAg carrier state | Q39662797 | ||
| Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. | Q41277179 | ||
| Precore sequence of hepatitis B virus inducing e antigen and membrane association of the viral core protein | Q41451798 | ||
| Contribution of low level HBV replication to continuing inflammatory activity in patients with anti-HBe positive chronic hepatitis B virus infection | Q43216710 | ||
| Detection and characterization of hepatitis B virus DNA in serum of HBe antigen-negative HBsAg carriers | Q43564515 | ||
| Latency and reactivation of a precore mutant hepatitis B virus in a chronically infected patient | Q43798496 | ||
| Hepatitis B virus DNA in the sera of HBsAg carriers: a marker of active hepatitis B virus replication in the liver. | Q44252034 | ||
| Perinatal transmission of the hepatitis B virus and of the HBV-associated delta agent from mothers to offspring in northern Italy | Q45792950 | ||
| Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus | Q45795119 | ||
| Natural history of chronic hepatitis B virus-related liver disease and its relationship to serum markers of viral replication | Q45830504 | ||
| Chronic persistent hepatitis type B can be a progressive disease when associated with sustained virus replication | Q45848808 | ||
| Active hepatitis B virus replication in the presence of anti-HBe is associated with viral variants containing an inactive pre-C region | Q45849206 | ||
| A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B. | Q45849284 | ||
| A new hepatitis B virus variant in a chronic carrier with multiple episodes of viral reactivation and acute hepatitis | Q45850121 | ||
| Rapid detection and further characterization of infection with hepatitis B virus variants containing a stop codon in the distal pre-C region | Q45850180 | ||
| Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen | Q61054126 | ||
| Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe | Q70029659 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatitis B | Q6853 |
| P304 | page(s) | 4186-4190 | |
| P577 | publication date | 1991-05-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis | |
| P478 | volume | 88 |
| Q45397200 | A complete genomic analysis of hepatitis B virus genotypes and mutations in HBeAg-negative chronic hepatitis B in China |
| Q37571503 | A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen |
| Q38526946 | A novel primer-extension assay for the detection of a G to A mutation in the distal precore region of hepatitis B virus DNA. |
| Q56979536 | A novel stop codon mutation within the hepatitis B surface gene is detected in the liver but not in the peripheral blood mononuclear cells of HIV-infected individuals with occult HBV infection |
| Q41331972 | A practical guide to the use of interferons in the management of hepatitis virus infections |
| Q71622433 | A randomized, double-blind, controlled trial of natural interferon-beta therapy for e-antigen-negative chronic hepatitis B patients with abnormal transaminase levels |
| Q41843085 | A survey of liver pathology in needle biopsies from HBsAg and anti-HBe positive individuals |
| Q35689607 | A treatment algorithm for the management of chronic hepatitis B virus infection in the United States |
| Q35053121 | A336C/A336T/T337C variations in HBV core gene and spontaneous hepatitis B e antigen loss in chronic hepatitis B patients |
| Q36309215 | Abnormal immunity and gene mutation in patients with severe hepatitis-B |
| Q30391932 | Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. |
| Q33841903 | Association of core promoter mutations of hepatitis B virus and viral load is different in HBeAg(+) and HBeAg(-) patients. |
| Q36841560 | Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma |
| Q45224986 | Characteristics of adefovir resistance in patients with or without lamivudine-resistant hepatitis B virus treated with adefovir: a 4-year experience |
| Q45368640 | Characterization of the basal core promoter and precore regions in anti-HBe-positive inactive carriers of hepatitis B virus |
| Q35621709 | Chronic hepatitis B e antigen (HBeAg) negative, anti-HBe positive hepatitis B: an overview |
| Q34002160 | Chronic hepatitis B. |
| Q45756207 | Clinical and molecular virological differences between fulminant hepatic failures following acute and chronic infection with hepatitis B virus |
| Q33879651 | Clinical efficacy of a 24-months course of lamivudine therapy in patients with HBeAg negative chronic hepatitis B: a long-term prospective study |
| Q35668730 | Clinical relevance of hepatitis B virus variants |
| Q34231638 | Clinical significance of hepatitis B virus (HBV) genotypes and precore and core promoter mutations affecting HBV e antigen expression in Taiwan |
| Q41474751 | Clinical, epidemiological and virological features of acute hepatitis B in Italy. |
| Q33651263 | Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination |
| Q45779448 | Coinfection study of precore mutant and wild-type hepatitis B-like virus in ducklings |
| Q44116425 | Colourimetric point mutation assay: for detection of precore mutants of hepatitis B |
| Q40707293 | Combination and evolution of HBV mutant strains in the HBeAg-positive status predict clinical outcomes after HBeAg seroconversion |
| Q40707285 | Combining the HBsAg decline and HBV DNA levels predicts clinical outcomes in patients with spontaneous HBeAg seroconversion |
| Q37365416 | Cytotoxic T cells and viral hepatitis |
| Q45742069 | Decrease of wild-type and precore mutant duck hepatitis B virus replication during lamivudine treatment in white Pekin ducks infected with the viruses |
| Q39401804 | Detection of hepatitis B pre-core mutant by allele specific polymerase chain reaction |
| Q45778427 | Detection of precore hepatitis B virus mutants in asymptomatic HBsAg-positive family members |
| Q33592384 | Development of a molecular-beacon assay to detect the G1896A precore mutation in hepatitis B virus-infected individuals |
| Q40817612 | Diagnostic markers of viral hepatitis B and C. |
| Q45750996 | Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion |
| Q27022216 | Direct acting antivirals for the treatment of chronic viral hepatitis |
| Q45769436 | Distribution of the predominant hepatitis B virus precore variants in hepatitis B e antigen-positive children and their effect on treatment response |
| Q36832325 | Drug resistance in antiviral treatment for infections with hepatitis B and C viruses |
| Q36201563 | Drugs in development for hepatitis B. |
| Q34179245 | Early termination of immune tolerance state of hepatitis B virus infection explains liver damage |
| Q39474534 | Effects of hepatitis B virus precore and basal core promoter mutations on the expression of viral antigens: genotype B vs C |
| Q35967369 | Emerging treatments in chronic hepatitis B. |
| Q64267288 | Epidemiology, Clinical Characteristics, and Management Status of Hepatitis B: A Cross-sectional Study in a Tertiary Care Hospital at Karachi, Pakistan |
| Q35073136 | European multicenter evaluation of high-density DNA probe arrays for detection of hepatitis B virus resistance mutations and identification of genotypes |
| Q73130886 | Evidence for selection of hepatitis B mutants after liver transplantation through peripheral blood mononuclear cell infection |
| Q35073559 | Expertise of laboratories in viral load quantification, genotyping, and precore mutant determination for hepatitis B virus in a multicenter study |
| Q35568019 | Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection |
| Q50585410 | Extended follow-up of anti-HBe-positive patients with chronic hepatitis B retreated with ribavirin and interferon-α |
| Q40466510 | Fibrosing cholestatic hepatitis and HBV after bone marrow transplantation |
| Q33297950 | Five subgenotypes of hepatitis B virus genotype B with distinct geographic and virological characteristics |
| Q42251194 | Full genome ultra-deep pyrosequencing associates G-to-A hypermutation of the hepatitis B virus genome with the natural progression of hepatitis B. |
| Q28298591 | Genetic Variations of the Hepatitis B Virus and Their Clinical Relevance |
| Q73343737 | HBV DNA levels and transmission of hepatitis B by health care workers |
| Q33801305 | HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection |
| Q37254285 | HLA-DP polymorphisms affect the outcomes of chronic hepatitis B virus infections, possibly through interacting with viral mutations |
| Q38859190 | Hepatitis B "e" antigen-mediated inhibition of HBV replication fitness and transcription efficiency in vitro |
| Q37571886 | Hepatitis B Virus e Antigen Regulates Monocyte Function and Promotes B Lymphocyte Activation |
| Q38776158 | Hepatitis B e antigen and its precursors promote the progress of hepatocellular carcinoma by interacting with NUMB and decreasing p53 activity. |
| Q58598672 | Hepatitis B e antigen inhibits NF-κB activity by interrupting K63-linked ubiquitination of NEMO |
| Q36651995 | Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: possible contribution of a single nucleotide in the precore region. |
| Q45368933 | Hepatitis B virus genotype B results in better immediate, late and sustained responses to peginterferon‐alfa in hepatitis‐B‐e‐antigen‐positive patients |
| Q43510252 | Hepatitis B virus genotypes in the United States: results of a nationwide study |
| Q45870499 | Hepatitis B virus precore mutants are identical in carriers from various ethnic origins and are associated with a range of liver disease severity |
| Q45769136 | Hepatitis B virus precore mutants in HBeAg carriers with chronic hepatitis treated with interferon |
| Q34124642 | Hepatitis B virus precore mutation and fulminant hepatitis in the United States. A polymerase chain reaction-based assay for the detection of specific mutation |
| Q35232789 | Hepatitis B viruses and hepatocellular carcinoma |
| Q37729188 | Hepatitis B-specific T helper cell responses in uninfected infants born to HBsAg+/HBeAg- mothers |
| Q33204408 | High frequency of the 1896 precore mutation in patients and blood donors with hepatitis B virus infection from the Indian subcontinent |
| Q45751000 | High prevalence of 1762(T) 1764(A) mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers. |
| Q42217489 | High risk of hepatitis B virus reactivation in nucleos(t)ide analogue-induced hepatitis B e antigen seroconverters older than 40 years |
| Q40633175 | Host immune response and variations in the virus genome: pathogenesis of liver damage caused by hepatitis B virus |
| Q59357583 | Identification of novel susceptibility loci associated with hepatitis B surface antigen seroclearance in chronic hepatitis B |
| Q34700332 | Immune response and tolerance during chronic hepatitis B virus infection |
| Q33835018 | Immune tolerance split between hepatitis B virus precore and core proteins |
| Q34416274 | Immunopathogenesis of hepatitis B e antigen negative chronic hepatitis B infection |
| Q37344233 | Immunopathology of hepatitis B virus infection |
| Q37196478 | Impact of Nucleotide Mutations at the HNF3- and HNF4-Binding Sites in Enhancer 1 on Viral Replication in Patients with Chronic Hepatitis B Virus Infection |
| Q35785174 | In vitro study of the effects of precore and lamivudine-resistant mutations on hepatitis B virus replication |
| Q45753677 | Incidence and clinical significance of hepatitis B virus precore gene translation initiation mutations in e antigen‐negative patients |
| Q45763604 | Increasing heterogeneity of the 'a' determinant of HBsAg found in the presumed late phase of chronic hepatitis B virus infection |
| Q45758549 | Influence of T‐helper cell subsets and crossregulation in hepatitis B virus infection |
| Q42244740 | JSH Guidelines for the Management of Hepatitis B Virus Infection |
| Q36153966 | KASL Clinical Practice Guidelines: Management of chronic hepatitis B |
| Q26752475 | KASL clinical practice guidelines: management of chronic hepatitis B |
| Q27468616 | Lamivudine/Adefovir Treatment Increases the Rate of Spontaneous Mutation of Hepatitis B Virus in Patients |
| Q92035063 | Large-scale viral genome analysis identifies novel clinical associations between hepatitis B virus and chronically infected patients |
| Q45744780 | Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen |
| Q28372760 | Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine |
| Q45397821 | Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection |
| Q24801344 | Low frequency of mutations in the core promoter and precore regions of hepatitis B virus in anti-HBe positive Brazilian carriers |
| Q38071403 | Management of acute hepatitis B and reactivation of hepatitis B |
| Q34328969 | Mathematical Models of E-Antigen Mediated Immune Tolerance and Activation following Prenatal HBV Infection |
| Q41667248 | Molecular biology of hepatitis B virus e antigen |
| Q37250341 | Molecular characteristics and stages of chronic hepatitis B virus infection |
| Q41870815 | Molecular characterization of hepatitis B virus X gene in chronic hepatitis B patients |
| Q34293921 | Mutant hepatitis B viruses: a matter of academic interest only or a problem with far-reaching implications? |
| Q45750470 | Mutations in the basic core promotor and the precore region of hepatitis B virus and their selection in children with fulminant and chronic hepatitis B. |
| Q33671155 | Naturally occurring variants of hepatitis B virus |
| Q38215650 | New perspective on the natural course of chronic HBV infection |
| Q41251653 | Nonresponse to hepatitis B vaccines and the kinetics of anti-HBs production |
| Q72408116 | Nucleotide sequence analysis of precore and proximal core regions in patients with chronic hepatitis B treated with interferon |
| Q72179901 | Nucleotide sequence analysis of the precore region in patients with spontaneous reactivation of chronic hepatitis B |
| Q45742072 | Olone modulates the therapeutic effect of interferon to eliminate preferentially the hepatitis B virus precore stop mutant |
| Q34539997 | Outbreak of hepatitis B virus infections associated with assisted monitoring of blood glucose in an assisted living facility-Virginia, 2010. |
| Q61054098 | Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study |
| Q46552174 | Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine |
| Q45763494 | Outcome of liver disease and response to interferon treatment are not influenced by hepatitis B virus core gene variability in children with chronic type B hepatitis |
| Q45765040 | Pathogenesis of chronic liver disease in patients with chronic hepatitis B virus infection without serum HBeAg |
| Q33925491 | Pathogenesis of hepatitis B virus infection |
| Q41556990 | Patients with interferon-induced HBeAg seroconversion have a higher risk of HBV reactivation and HBeAg seroreversion |
| Q37267440 | Peripheral T-lymphocyte subpopulations in different clinical stages of chronic HBV infection correlate with HBV load |
| Q73523464 | Persistence of viral replication after anti-HBe seroconversion during antiviral therapy for chronic hepatitis B |
| Q45416046 | Possible association of vigorous hepatitis B virus replication with the development of fulminant hepatitis |
| Q34552034 | Potent antiviral therapy improves survival in acute on chronic liver failure due to hepatitis B virus reactivation |
| Q73246101 | Pre-core mutant infections in the Canadian Inuit |
| Q45766435 | Pre-core mutants of hepatitis B virus in patients receiving immunosuppressive treatment after orthotopic liver transplantation |
| Q33945490 | Precore Stop Mutant in HBeAg-Positive Patients with Chronic Hepatitis B: Clinical Characteristics and Correlation with the Course of HBeAg-to-Anti-HBe Seroconversion |
| Q46219118 | Precore and basal core promoter mutations in Asian American patients with hepatitis B e antigen‐positive chronic hepatitis B |
| Q36535912 | Precore mutant of hepatitis B virus prevails in acute and chronic infections in an area in which hepatitis B is endemic |
| Q45782497 | Precore region mutation in hepatitis B virus genome in early stage of infection: a study in hepatitis B e antigen-positive young carriers |
| Q74027206 | Precore wild-type DNA and immune complexes persist in chronic hepatitis B after seroconversion: No association between genome conversion and seroconversion |
| Q40045731 | Precore-mediated inhibition of hepatitis B virus progeny DNA synthesis. |
| Q45361924 | Precore/core promoter mutations and hepatitis B virus genotype in hepatitis B and C dually infected patients treated with interferon-based therapy |
| Q33764123 | Prevalence and Characteristics of Precore Mutation in Iran and Its Correlation with Genotypes of Hepatitis B. |
| Q45788252 | Prevalence of precore‐defective mutant of hepatitis B virus in HBV carriers |
| Q74497588 | Prevention of severe hepatic injury by interferon-α in chronic active hepatitis lacking HBeAg (mutant strain) in a patient with malignant lymphoma |
| Q45749810 | Progression of the proportion of hepatitis B virus precore stop mutant following acute superinfection of hepatitis C. |
| Q35840358 | Quantitative dynamics of hepatitis B basal core promoter and precore mutants before and after HBeAg seroconversion |
| Q39848558 | Rapid and sensitive assays for determination of hepatitis B virus (HBV) genotypes and detection of HBV precore and core promoter variants |
| Q45740320 | Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity |
| Q44902829 | Rare pre-core stop-codon mutant nt. 1897 predominates over wide-spread mutant nt. 1896 in an unusual course of chronic hepatitis B. |
| Q36150595 | Reactivation of hepatitis B virus with rituximab. |
| Q40484914 | Recent advances in the molecular biology of hepatitis B virus: mutant virus and the host response |
| Q43993353 | Relationship of clinical and virological factors with hepatitis activity in hepatitis B e antigen-negative chronic hepatitis B virus-infected patients |
| Q45765645 | Semiquantitative assessment of pre-core stop-codon mutant and wildtype hepatitis B virus during the course of chronic hepatitis B using a new PCR-based assay |
| Q43993339 | Sequential analysis of hepatitis B virus core promoter and precore regions in cancer survivor patients with chronic hepatitis B before, during and after interferon treatment |
| Q27470232 | Stealth and cunning: hepatitis B and hepatitis C viruses |
| Q34205905 | TGF-β1 Down-Regulation of NKG2D/DAP10 and 2B4/SAP Expression on Human NK Cells Contributes to HBV Persistence |
| Q45256268 | The Hepatitis B Virus e Antigen Cannot Pass the Murine Placenta Efficiently and Does Not Induce CTL Immune Tolerance in H-2bMicein Utero |
| Q35664171 | The chimpanzee model for hepatitis B virus infection |
| Q39474523 | The hepatitis B e antigen suppresses IL-1β-mediated NF-κB activation in hepatocytes |
| Q35879066 | The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype. |
| Q35784981 | The level of viral antigen presented by hepatocytes influences CD8 T-cell function. |
| Q64132783 | The natural history of chronic hepatitis B virus infection |
| Q33937762 | The precore gene of the woodchuck hepatitis virus genome is not essential for viral replication in the natural host |
| Q45757308 | The two different states of hepatitis B virus DNA in asymptomatic carriers: HBe-antigen-positive versus anti-HBe-positive asymptomatic carriers |
| Q37021822 | Therapeutic strategies in the management of patients with chronic hepatitis B virus infection. |
| Q43892791 | There were no differences in serum HBV DNA level between HBeAg-positive and HBeAg-negative chronic hepatitis B with same liver histological necroinflammation grade but differences among grades 1, 2, 3 and 4 apportioned by the same hepatic parenchyma |
| Q44248105 | Uncommon mutation pattern of a hepatitis B virus isolate from genotype F infecting a patient with AIDS. |
| Q33753991 | Understanding the Complex Patterns Observed during Hepatitis B Virus Therapy. |
| Q37195244 | Understanding the immunopathogenesis of chronic hepatitis B virus: an Asian prospective. |
| Q35938992 | Universal emergence of precore mutant hepatitis B virus along with seroconversion to anti-HBe irrespective of subsequent activity of chronic hepatitis B. |
| Q40966818 | Update on viral hepatitis in children |
| Q43030555 | Virological analysis, genotypes and mutational patterns of the HBV precore/core gene in HBV/HCV-related hepatocellular carcinoma. |
| Q34536159 | World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants |
Search more.